Back to mobile site

More on LRMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+41.0% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Larimar Therapeutics (NQ:LRMR)
Delayed: 3.87 -0.06 (1.53%)
Prev. Close $3.93  
Open$3.93 
52 Wk High$ 
52 Wk Low$ 
Day High$4.12 
Day Low$3.84 
P/E N/A  
EPS$ 
Volume910,556 

Friends, Peers and Foes (?): IPSC, KBLB, META, MVRS, VIR (more...)

Sep 14, 2026 06:06 AM Leerink Starts Larimar Therapeutics (LRMR) at Outperform
Sep 9, 2026 04:05 PM Century Therapeutics names Joseph Truitt to its board of directors
Sep 9, 2026 04:05 PM Century Therapeutics Appoints Joseph Truitt to Board of Directors
Aug 4, 2026 07:24 AM Larimar Therapeutics, Inc. (LRMR) Tops Q2 EPS by 8c
Aug 4, 2026 07:12 AM Form 10-Q Larimar Therapeutics, For: Jun 30
Aug 4, 2026 07:03 AM Form 8-K Larimar Therapeutics, For: Aug 04
Aug 4, 2026 07:00 AM Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Jul 8, 2026 04:05 PM Form 4 Larimar Therapeutics, For: Jul 06 Filed by: Hamilton Thomas Edward
Jul 7, 2026 05:21 AM Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens
Jul 2, 2026 06:05 AM H.C. Wainwright Assumes Larimar Therapeutics (LRMR) at Buy
View All Articles

Entities mentioned with LRMR

View All Entities